Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Harvard Bioscience (HBIO) over the last 16 years, with Q3 2025 value amounting to $324000.0.

  • Harvard Bioscience's Share-based Compensation fell 6923.08% to $324000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 5049.36%. This contributed to the annual value of $4.3 million for FY2024, which is 1320.0% down from last year.
  • Latest data reveals that Harvard Bioscience reported Share-based Compensation of $324000.0 as of Q3 2025, which was down 6923.08% from $472000.0 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Share-based Compensation ranged from a high of $1.4 million in Q4 2023 and a low of $324000.0 during Q3 2025
  • For the 5-year period, Harvard Bioscience's Share-based Compensation averaged around $1.0 million, with its median value being $1.0 million (2024).
  • As far as peak fluctuations go, Harvard Bioscience's Share-based Compensation skyrocketed by 5136.54% in 2021, and later crashed by 6923.08% in 2025.
  • Over the past 5 years, Harvard Bioscience's Share-based Compensation (Quarter) stood at $1.0 million in 2021, then dropped by 2.23% to $1.0 million in 2022, then skyrocketed by 36.83% to $1.4 million in 2023, then tumbled by 30.46% to $961000.0 in 2024, then tumbled by 66.29% to $324000.0 in 2025.
  • Its last three reported values are $324000.0 in Q3 2025, $472000.0 for Q2 2025, and $600000.0 during Q1 2025.